CHRISTINE SUNG: Open Payments
NPI 1316532872 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,665 in 80 payments from 14 companies in 2025. Trend: 2023 $1,100 · 2024 $1,672 · 2025 $1,665
Food & beverage: $1,566Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $407 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $302 |
| Janssen Biotech, Inc. | 16 | $215 |
| UCB, Inc. | 12 | $165 |
| E.R. Squibb & Sons, L.L.C. | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 6 | $110 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Incyte Corporation | 3 | $73 |
| Arcutis Biotherapeutics, Inc. | 3 | $59 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $42 |
Products named: SKYRIZI, TREMFYA, Bimzelx, Sotyktu, COSENTYX, Leqselvi, OPZELURA, ILUMYA.
Industry payments across CA — which companies pay providers there.
